Circulating CD8+CD122+ T cells as a prognostic indicator of pancreatic cancer

Overview of attention for article published in BMC Cancer, November 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 977 followers.

@vibronet Check out Mirati's MRTX1133 KRAS inhibitor + afatinib. PCNA inibitor (AOH1996)? I haven't found anybody working on CD8+ CD122+ T cells yet, but they tend to swell in numbers near cancers https://t.co/LEflvsgCv9 Fig 1 top mutations in KRAS, TP53,

02 Aug 2023

Reply Repost Favourite

New article: Circulating CD8+CD122+ T cells as a prognostic indicator of pancreatic cancer https://t.co/5V0AmUokh1 #pancreaticcancer #oncology https://t.co/OtaADBo1Np

05 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.